ABOUT US

Date of establishment 2015/01/22
The amount of capital NT$214 million
Chairman of the board Ken Cheng
Business Area
  • Cancer Drugs Development:
    Breast cancer、Liver cancer、Lung cancer、Colo-rectal cancer、Kidney cancer、Oral cancer、Skin Cancer…cancer drugs development.
  • Precision Medicine:
    Cancer Tumor Metastasis Detect
  • Stem cell application and development:
    Focus on epigenetic modification of stem cell which will regulate cell differentiation.
Headquarters 3F., No.11, Ln. 77, Xing’ai Rd., Neihu Dist., Taipei City 114, Taiwan
Laboratory 3F., No.13, Ln. 77, Xing’ai Rd., Neihu Dist., Taipei City 114, Taiwan
Falvguwen Lee and Li, Attorneys-at-Law
Patent advisors M.Y.Ho Patent Office division